Ezra E.W. Cohen, MD, on Immunotherapy for Head and Neck Cancer
Posted: Saturday, October 20, 2018
Ezra E.W. Cohen, MD, of the University of California, San Diego, discusses the effectiveness of anti–PD-1 therapy in patients with recurrent head and neck cancer, current treatment recommendations, and the studies that might help clinicians improve treatment for those who will benefit.